The American Society of Addiction Medicine (ASAM) is accepting rolling submissions for clinical guidance document topics.
If you are interested in submitting a clinical guidance topic, please complete the form below. Topic nominations are regularly reviewed by the ASAM Clinical Practice Guideline-Methodology and Oversight Committee. If you have questions, please contact us at quality@asam.org.
ASAM’s Clinical Practice Guideline & Methodology Oversight Committee and the Quality Improvement Council (QIC) will review all nominated topics based on the following criteria:
- Importance as determined by the prevalence of the condition, effect of the condition on morbidity and mortality.
- Relevance to Addiction Medicine practice by addressing addiction prevention, screening, diagnosis, and treatment of conditions within the scope of Addiction Medicine.
- Availability of evidence to guide development.
- Likelihood that a clinical guidance document will improve addiction practice and care (e.g., Lack of consensus in the field or guidance does not already exist on the topic).
- Need for a clinical guidance document including evidence of a quality gap, time since publication of guidance on the topic by ASAM or other organizations, etc.
If the topic is selected, the QIC will select the writing group committee members and chairs. Nomination of a topic is not a factor in determining participation on the expert committee. A national search for experts is conducted for all clinical documents developed by ASAM.
The QIC will also determine the document type for selected topics. ASAM develops three types of clinical guidance documents: clinical practice guidelines, clinical consensus statements, and clinical considerations.
Clinical Practice Guidelines are the most scientifically rigorous, time-intensive documents, and require a formal systematic literature review to inform the recommendations. Approximate time to completion: 2+ years
Clinical Consensus Statements are informed by evidence, but may include a broader scope of evidence, such as case studies and reviews, including scoping literature reviews. Clinical Consensus Statements use expert clinical consensus on high-priority topics that may have conflicting or limited evidence. Approximate time to completion: 1.5-2 years
Clinical Consideration documents address issues that are immediately clinically relevant, though they may have limited evidence. Clinical Considerations are typically informed by narrative literature reviews and based on expert clinical consensus. These are smaller in scope to allow for development in approximately 3-6 months.